Multi-omics integration identifies a gut-microbiota-associated plasma metabolite signature for alzheimer disease diagnosis and metabolic pathway targeting
Background Alzheimer’s disease (AD) is the leading cause of dementia, with early diagnosis remaining constrained by the invasiveness and limited accessibility of current biomarkers. The gut–brain axis has emerged as a critical communication network linking intestinal homeostasis with central nervous system function, ye...